| 72.0919 0.592 (0.83%) | 10-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 85.54 |
1-year : | 99.91 |
| Resists | First : | 73.23 |
Second : | 85.54 |
| Pivot price | 71.51  |
|||
| Supports | First : | 71.35 |
Second : | 70.19 |
| MAs | MA(5) : | 71.73 |
MA(20) : | 71.68 |
| MA(100) : | 74.21 |
MA(250) : | 67.74 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 55.9 |
D(3) : | 51.1 |
| RSI | RSI(14): 50.4 |
|||
| 52-week | High : | 77.71 | Low : | 55.44 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ SCDS ] has closed below upper band by 28.0%. Bollinger Bands are 19.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 72.51 - 72.87 | 72.87 - 73.23 |
| Low: | 70.81 - 71.19 | 71.19 - 71.57 |
| Close: | 71.49 - 72.08 | 72.08 - 72.68 |
Typically, this fund commits a minimum of 80% of its capital to small-capitalization equity holdings. A substantial number of the companies represented in the portfolio operate within the financial, industrial, and healthcare industries. The fund's adviser implements an advanced investment methodology, driven by fundamental data science, that synergistically merges in-depth research, actionable data insights, and comprehensive risk oversight.
Mon, 10 Aug 2026
The Data Science Disconnect: High Performance With Low Assets - ETF Database
Mon, 08 Jun 2026
CALF: Quality Small-Cap Exposure Lacking A Clear Performance Edge (BATS:CALF) - Seeking Alpha
Mon, 29 Sep 2025
ETFs investiert in Amylyx Pharmaceuticals, Inc.-Aktien - TradingView
Thu, 05 Sep 2024
JPMorgan establishes private banking team in Dubai - Private Banker International
Thu, 08 Aug 2024
SCDS ETF Price and Chart — NASDAQ:SCDS - TradingView
Mon, 27 Sep 2021
THRY Stock Price and Chart — NASDAQ:THRY - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|